SCHEMBL470784

SCHEMBL470784

O=c1c2ccccc2c2c1c1c3ccccc3c(=O)c1c1c3ccccc3c(=O)c21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 1/20 0.48
ALDH1A1 P00352 4/20 0.42
MAOA P21397 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HPGD P15428 3/20 0.42
KDM4E B2RXH2 3/20 0.42
MAPT P10636 3/20 0.42
GAA P10253 3/20 0.42
GLA P06280 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 1/20 0.42
ATM Q13315 1/20 0.42
CYP3A4 P08684 1/20 0.42
PGAM1 P18669 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
POLB P06746 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30019620 1.00 S100A4 (0.48) S100A4ALDH1A1MAOASMN1; SMN2HPGD
SCHEMBL29425353 1.00 S100A4 (0.48) S100A4ALDH1A1MAOASMN1; SMN2HPGD
SCHEMBL25234735 1.00 S100A4 (0.48) S100A4ALDH1A1MAOASMN1; SMN2HPGD
SCHEMBL29713419 1.00 S100A4 (0.48) S100A4ALDH1A1MAOASMN1; SMN2HPGD
SCHEMBL5017301 0.94 S100A4 (0.48) S100A4ALDH1A1MAOASMN1; SMN2HPGD
SCHEMBL20669045 0.94 S100A4 (0.48) S100A4ALDH1A1MAOASMN1; SMN2HPGD
SCHEMBL11049489 0.94 S100A4 (0.48) S100A4ALDH1A1MAOASMN1; SMN2HPGD
SCHEMBL7905111 0.94 S100A4 (0.52) S100A4ALDH1A1MAOASMN1; SMN2HPGD
SCHEMBL20669039 0.89 S100A4 (0.42) S100A4ALDH1A1MAOASMN1; SMN2HPGD
SCHEMBL20669047 0.88 S100A4 (0.45) S100A4ALDH1A1MAOASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240062782-A1 NONLINEAR LIGHT ABSORPTION MATERIAL, RECORDING MEDIUM, METHOD FOR RECORDING INFORMATION, AND METHOD FOR READING INFORMATION PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2024-02-22 US disclosed
US-20230203299-A1 RESIST UNDERLAYER FILM- FORMING COMPOSITION USING DIARYLMETHANE DERIVATIVE NISSAN CHEMICAL CORPORATION (JP) 2023-06-29 US disclosed
US-20230203299-A1 RESIST UNDERLAYER FILM- FORMING COMPOSITION USING DIARYLMETHANE DERIVATIVE NISSAN CHEMICAL CORPORATION (JP) 2023-06-29 US disclosed
WO-2022244430-A1 NONLINEAR LIGHT ABSORBING MATERIAL, RECORDING MEDIUM, METHOD FOR RECORDING INFORMATION, AND METHOD FOR READING INFORMATION パナソニックIPマネジメント株式会社 2022-11-24 WO disclosed
US-11126084-B2 Composition for resist underlayer film formation, resist underlayer film and forming method thereof, production method of patterned substrate, and compound JSR CORPORATION (JP) 2021-09-21 US disclosed
US-10615045-B2 Composition for forming organic film, patterning process, and resin for forming organic film SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-04-07 US disclosed
US-10444628-B2 Compound for forming organic film, composition for forming organic film, method for forming organic film, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-10-15 US disclosed
US-20190243247-A1 COMPOSITION FOR RESIST UNDERLAYER FILM FORMATION, RESIST UNDERLAYER FILM AND FORMING METHOD THEREOF, PRODUCTION METHOD OF PATTERNED SUBSTRATE, AND COMPOUND JSR CORPORATION (JP) 2019-08-08 US disclosed
US-20190027369-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND RESIN FOR FORMING ORGANIC FILM SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-01-24 US disclosed
EP-2714659-B1 COMPOUNDS WITH OXIME ESTER AND/OR ACYL GROUPS AMERICAN DYE SOURCE INC (CA) 2017-07-05 EP disclosed
US-9127017-B2 Compounds with oxime ester and/or acyl groups AMERICAN DYE SOURCE, INC. (CA) 2015-09-08 US disclosed
US-9127017-B2 Compounds with oxime ester and/or acyl groups AMERICAN DYE SOURCE, INC. (CA) 2015-09-08 US disclosed
US-20140200350-A1 COMPOUNDS WITH OXIME ESTER AND/OR ACYL GROUPS AMERICAN DYE SOURCE, INC. (CA) 2014-07-17 US disclosed
US-20140200350-A1 COMPOUNDS WITH OXIME ESTER AND/OR ACYL GROUPS AMERICAN DYE SOURCE, INC. (CA) 2014-07-17 US disclosed
US-20140144509-A1 Compounds for Organic Photovoltaic Devices NOVALED AG (DE) 2014-05-29 US disclosed
US-20140144509-A1 Compounds for Organic Photovoltaic Devices NOVALED AG (DE) 2014-05-29 US disclosed
US-20140144509-A1 Compounds for Organic Photovoltaic Devices NOVALED AG (DE) 2014-05-29 US disclosed
WO-2012159213-A1 COMPOUNDS WITH OXIME ESTER AND/OR ACYL GROUPS AMERICAN DYE SOURCE, INC. (CA) 2012-11-29 WO disclosed
WO-2012110402-A1 TRISAZO COMPOUNDS, PROCESSES FOR PREPARING THEM AND USE THEREOF SENSIENT IMAGING TECHNOLOGIES GMBH (DE) 2012-08-23 WO disclosed
WO-2012031735-A1 COMPOUNDS FOR ORGANIC PHOTOVOLTAIC DEVICES NOVALED AG (DE) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11126084-B2 Composition for resist underlayer film formation, resist underlayer film and forming method thereof, production method of patterned substrate, and compound EMG1, FN1, TOP1 S100A4 623/4885ALDH1A1 849/4885MAOA 714/4885
US-10444628-B2 Compound for forming organic film, composition for forming organic film, method for forming organic film, and patterning process CHRM1, OR10J3, MYB S100A4 815/4885ALDH1A1 2205/4885MAOA 317/4885
US-20190243247-A1 COMPOSITION FOR RESIST UNDERLAYER FILM FORMATION, RESIST UNDERLAYER FILM AND FORMING METHOD THEREOF, PRODUCTION METHOD OF PATTERNED SUBSTRATE, AND COMPOUND EMG1, FN1, TOP1 S100A4 623/4885ALDH1A1 849/4885MAOA 714/4885
US-20140200350-A1 COMPOUNDS WITH OXIME ESTER AND/OR ACYL GROUPS PPOX, SCO2, LPO S100A4 2681/4885ALDH1A1 275/4885MAOA 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.